NBP
NovaBridge Biosciences
1.40$
+0.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -230.0% | – | – | – | -211.0% | – | – | – | |
| – | – | – | – | – | +8.7% | – | – | – | -86.0% | +917.3% | -0.3% | – | |
| – | -56.8% | -147.2% | – | -74.5% | -60.9% | +164.3% | -1.3% | +382.6% | -62.0% | -13.9% | -0.3% | – | |
| – | – | – | – | – | -106.3% | – | – | – | -79.4% | -128.1% | – | – | |
| – | – | – | – | – | +3,700.0% | -100.0% | – | – | -100.0% | – | -0.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -0.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -100.7% | – | -0.3% | – | |
| – | – | – | – | – | – | – | – | – | -103.9% | – | – | – | |
| – | – | – | – | – | -230.5% | – | – | – | -211.0% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.